Abbott Medical Devices

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Activity

Recent Activity

Last 14 days

Sep 12, 2026

Recruiting

Cephea Early Feasibility Study

Sep 12, 2026

Enrolling by invitation

Evaluation of the Navitor Transcatheter Heart Valve in Low and Intermediate Risk Patients Who Have Severe, Symptomatic, Aortic Stenosis Requiring Aortic Valve Replacement

Sep 12, 2026

Active, not recruiting

Cephea South America Feasibility Study

Sep 11, 2026

Recruiting

Abbott Cephea Mitral Valve Disease Registry

Sep 9, 2026

Active, not recruiting

TECTONIC CAD Intravascular Lithotripsy (IVL) IDE Study

Earlier

Sep 3, 2026TrialA Post-Market Assessment of the Safety and Performance of the TriClip™ System (TREAT TR)

Sep 2, 2026TrialAbbott Structural Heart Device Registry

Aug 29, 2026TrialTreatment ResistAnt Depression Subcallosal CingulatE Network DBS

4 more events

Aug 14, 2026TrialAmplatzer Amulet China Post Market Study (PMS)

Aug 12, 2026TrialPost Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Korea (Korea HM3 PMS)

Aug 7, 2026TrialVOLT-AF IDE Clinical Study

Aug 5, 2026TrialAbbott Medical - VERITAS Study

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)